Abstract
Laboratory and field trials were conducted to determine the efficacy of the candidate rodenticide flupropadine against the house mouse (Mus musculus L.). In laboratory feeding tests, family groups of wild mice maintained in pens and conditioned to feeding on plain foods were offered flupropadine at either 0.10%, 0.15%, 0.18% or 0.20% in pinhead oatmeal bait. Overall mortalities in replicated 21-day treatments were 66/71 (93.0%), 71/79 (89.9%), 72/76 (94.7%) and 69/75 (92.0%) respectively. In 17 field trials carried out against mice infesting farm buildings, flupropadine was used at 0.10%, 0.15% and 0.18% in oatmeal bait. Mean treatment success, estimated from live-capture and mortality data, was 88.6%, 96.2% and 96.6% respectively. Flupropadine was found to be as near effective against mice as calciferol/warfarin and the second-generation anticoagulant rodenticides difenacoum, bromadiolone and brodifacoum. In further comparison with the anticoagulants, treatment with flupropadine bait achieved markedly quicker control.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Rowe F. P., Bradfield A. Trials of the anticoagulants rodenticide WBA 8119 against confined colonies of warfarin-resistant house mice (Mus musculus L.). J Hyg (Lond) 1976 Dec;77(3):427–431. [PubMed] [Google Scholar]
- Rowe F. P., Plant C. J., Bradfield A. Trials of the anticoagulant rodenticides bromadiolone and difenacoum against the house mouse (Mus musculus L.). J Hyg (Lond) 1981 Oct;87(2):171–177. doi: 10.1017/s0022172400069370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rowe F. P., Smith F. J., Swinney T. Field trials of calciferol combined with warfarin against wild house-mice (Mus musclus L.). J Hyg (Lond) 1974 Dec;73(3):353–360. doi: 10.1017/s0022172400042698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rowe F. P., Swinney T., Plant C. Field trials of brodifacoum (WBA 8119) against the house mouse (Mus musculus L.). J Hyg (Lond) 1978 Oct;81(2):197–201. doi: 10.1017/s002217240002502x. [DOI] [PMC free article] [PubMed] [Google Scholar]